Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis.

Mason LaiCynthia FentonJin Ge Jessica B Rubin Jennifer C Lai Giuseppe Cullaro

Published in: Hepatology communications (2023)

NSBB use is associated with Stage 2 AKI and WLM in patients awaiting liver transplantation and Child C cirrhosis. These data suggest cautious use of NSBBs in patients in this population.

Keyphrases

acute kidney injury
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
mental health
prognostic factors
cardiac surgery
risk factors
cardiovascular disease
patient reported outcomes
coronary artery disease
deep learning
data analysis